A comparison of the prevalence of premenstrual dysphoric disorder and comorbidities among adolescents in the united states of america and nigeria

Journal of Pediatric and Adolescent Gynecology

Volumn 24, Issue 6, 2011, Pages 397-403

  Ogebe, Ori ^a   Abdulmalik, Jibril ^b   Bello Mojeed, Mashudat A ^c   Holder, Nneka ^a   Jones, Heather A ^a   Ogun, Oluwayemi O ^c   Omigbodun, Olayinka ^d  

^a AKRON CHILDREN'S HOSPITAL   (United States)

^b Federal Neuro Psychiatric Hospital   (Nigeria)

^c Federal Neuropsychiatric Hospital   (Nigeria)

^d UNIVERSITY OF IBADAN   (Nigeria)

Author keywords

Adolescent; Cultures; Nigeria; Premenstrual dysphoria; Premenstrual syndrome; Prevalence

Indexed keywords

ADOLESCENT; ADULT; ANXIETY; ARTICLE; BLOATING; BREAST TENDERNESS; COMORBIDITY; CONFUSION; CONTROLLED STUDY; CULTURAL ANTHROPOLOGY; DEPRESSION; DISEASE SEVERITY; FEMALE; HEADACHE; HOSPITAL; HUMAN; INTERVIEW; IRRITABILITY; LIMB SWELLING; MAJOR CLINICAL STUDY; MOOD DISORDER; MORBIDITY; MULTICENTER STUDY; NIGERIA; OUTPATIENT; POSTTRAUMATIC STRESS DISORDER; PREMENSTRUAL DYSPHORIC DISORDER; PREMENSTRUAL SYNDROME; PREVALENCE; PRIORITY JOURNAL; SCREENING; SUICIDAL IDEATION; UNITED STATES;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MOOD DISORDERS; NIGERIA; PREMENSTRUAL SYNDROME; PREVALENCE; QUESTIONNAIRES; SUICIDAL IDEATION; UNITED STATES; YOUNG ADULT;

EID: 81255197558     PISSN: 10833188     EISSN: 18734332     Source Type: Journal    
DOI: 10.1016/j.jpag.2011.07.009     Document Type: Article

References (17)

1. Rapkin A.J., Mikacich J.A. Premenstrual syndrome in adolescents: diagnosis and treatment. Pediatr Endocrinol Rev 2006, 3(Suppl 1):132-137.
2. Steiner M. Premenstrual syndrome and premenstrual dysphoric disorder: guidelines for management. J Psychiatry Neurosci 2000, 25:459-468.
3. Htay TT: Premenstrual dysphoric disorder: eMedicine Psychiatry. Accessed December 29, 2010. http://emedicine.medscape.com/article/293257-overview.
4. Pinna G., Costa E., Guidotti A. Fluoxetine and norfluoxetine stereospecifically and selectively increase brain neurosteroid content at doses that are inactive on 5-HT reuptake. Psychopharmacology (Berl) 2006, 186:362-372.
5. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders Text Revision 1994, American Psychiatric Association, Washington, DC, p 774. 4th ed.
6. Adewuya A.O., Loto O.M., Adewumi T.A. Premenstrual dysphoric disorder amongst Nigerian university students: prevalence, comorbid conditions, and correlates. Arch Womens Ment Health 2008, 11:13-18.
7. Gehlert S., Hartlage S. A design for studying the DSM-IV research criteria of premenstrual dysphoric disorder. J Psychosom Obstet Gynaecol 1997, 18:36-44.
8. Wittchen H.U., Becker E., Lieb R., Krause P. Prevalence, incidence and stability of premenstrual dysphoric disorder in the community. Psychol Med 2002, 32:119-132.
9. Silber T.J., Valadez-Meltzer A. Premenstrual dysphoric disorder in adolescents: case reports of treatment with fluoxetine and review of the literature. J Adolesc Health 2005, 37:518-525.
10. Halbreich U., Borenstein J., Pearlstein T., et al. The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD). Psychoneuroendocrinology 2003, 28(Suppl 3):1-23.
11. Breaux C., Hartlage S., Gehlert S. Relationships of premenstrual dysphoria to major depression and anxiety disorders: a reexamination. J Psychosom Obstet Gynaecol 2000, 21:17-24.
12. Hartlage S.A., Arduino K.E., Gehlert S. Premenstrual dysphoric disorder and risk for major depressive disorder: a preliminary study. J Clin Psychol 2001, 57:1571-1578.
13. Nigeria Demographic and Health Survey (NDHS) 2008 Report. Accessed January31, 2011. http://www.measuredhs.com/pubs/pdf/sr173/sr173.pdf-24.
14. Steiner M., Macdougall M., Brown E. The premenstrual symptoms screening tool (PSST) for clinicians. Arch Womens Ment Health 2003, 6:203-209.
15. Sheehan D.V., Lecrubier Y., Sheehan K.H., et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998, 59(Suppl 20). 22-33;quiz 34-57.
16. Lewis's Child and Adolescent Psychiatry 2007, 538-548. Lippincott Williams and Wilkins, Philadelphia. (4th ed). A. Martin, F.R. Volkmar (Eds.).
17. Perkonigg A., Yonkers K.A., Pfister H., et al. Risk factors for premenstrual dysphoric disorder in a community sample of young women: the role of traumatic events and posttraumatic stress disorder. J Clin Psychiatry 2004, 65:1314-1322.